依达拉奉治疗急性脑梗塞的临床疗效评价

摘要

Objective To analyze the clinical effect of edaravone on acute cerebral infarction. Methods This study included 56 cases of acute cerebral Infarction as selecting objects in our hospital in November 2013 to May 2015, according to the hospitalization time, they were divided into two groups of observation and control, and accepted edaravone and Yinxingdamo respectively, and compare their clinical effcacy. Results The observation clinical effective rate was higher than that in control group after treatment, the difference was statistically signiifcant, P<0.05. Conclusion Edaravone and low-molecular heparin calcium for patients with acute cerebral infarction can improve clinical outcomes, with a certain security and reliability.%目的：分析依达拉奉对急性脑梗塞的临床治疗效果。方法此研究选择的56例纳入对象均为我院在2013年11月～2015年5月接受的急性脑梗塞患者，依据入院的先后顺序将其分为观察组以及对照组，并在治疗中分别采用依达拉奉以及银杏达莫，比较两组临床疗效。结果观察组经治疗后其临床有效率高于对照组，结果差异具有统计学意义，P＜0.05。结论对急性脑梗塞患者采用依达拉奉联合低分子肝素钙进行治疗，能够提升临床治疗效果，在使用过程中具有一定的安全可靠性。